S 3322 New Jersey Senate · 2026-2027 Regular Session

Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.

This bill (S 3322) requires New Jersey to create a central registry for newborns diagnosed with sickle cell trait - a genetic condition where a person carries one sickle cell gene but typically does not have sickle cell disease. It mandates that newborn screening labs notify physicians, who must then provide parents with information about genetic counseling. The registry will track cases to ensure parents receive timely notifications during early adolescence (for athletic safety) and later adolescence (for reproductive planning), while keeping all health data confidential. The bill directly affects newborns with sickle cell trait and their families in New Jersey.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 5, 2026 Last action Feb 5, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Feb 5, 2026
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Shirley Turner
Shirley Turner
DDemocratic
NJ
15